1-5 of 5
Lasse Teerenhovi
Close
Sort by
Journal Articles

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

Clinical Trials & Observations
Eva Ösby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm
Journal: Blood
Blood (2003) 101 (10): 3840–3848.
https://doi.org/10.1182/blood-2002-10-3238
Published: 2003
Journal Articles

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients

Clinical Trials & Observations
Petri Salven, Arto Orpana, Lasse Teerenhovi, Heikki Joensuu
Journal: Blood
Blood (2000) 96 (12): 3712–3718.
https://doi.org/10.1182/blood.V96.12.3712
Published: 2000
Journal Articles

A High Pretreatment Serum Basic Fibroblast Growth Factor Concentration Is an Independent Predictor of Poor Prognosis in Non-Hodgkin’s Lymphoma

Petri Salven, Lasse Teerenhovi, Heikki Joensuu
Journal: Blood
Blood (1999) 94 (10): 3334–3339.
https://doi.org/10.1182/blood.V94.10.3334.422k18_3334_3339
Published: 1999
Journal Articles

Elevated Serum CD44 Level Is Associated With Unfavorable Outcome in Non-Hodgkin's Lymphoma

Raija Ristamäki, Heikki Joensuu, Kimmo Lappalainen, Lasse Teerenhovi, Sirpa Jalkanen
Journal: Blood
Blood (1997) 90 (10): 4039–4045.
https://doi.org/10.1182/blood.V90.10.4039
Published: 1997
Journal Articles

A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's Lymphoma

Petri Salven, Lasse Teerenhovi, Heikki Joensuu
Journal: Blood
Blood (1997) 90 (8): 3167–3172.
https://doi.org/10.1182/blood.V90.8.3167
Published: 1997